AI Verdict
PUBC has stronger fundamentals based on our AI analysis.
PUBC vs PTIXW Fundamental Comparison
| Metric | PUBC | PTIXW |
|---|---|---|
| Revenue | $285,435.0 | $0.0 |
| Net Income | $-2.3M | $-3.7M |
| Net Margin | -798.7% | N/A |
| ROE | N/A | N/A |
| ROA | -1,014.5% | -83.9% |
| Current Ratio | 0.04x | 0.34x |
| Debt/Equity | N/A | N/A |
| EPS | $-0.01 | $-1.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PUBC vs PTIXW: Frequently Asked Questions
Is PUBC or PTIXW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PUBC has stronger fundamentals. PUBC is rated STRONG SELL (95% confidence) while PTIXW is rated STRONG SELL (88% confidence). This is not investment advice.
How does PUBC compare to PTIXW fundamentally?
Purebase Corp has ROE of N/A vs Protagenic Therapeutics, Inc.new's N/A. Net margins are -798.7% vs N/A respectively.
Which stock pays higher dividends, PUBC or PTIXW?
PUBC has a dividend yield of N/A or no dividend while PTIXW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PUBC or PTIXW for long term?
For long-term investing, consider that PUBC has STRONG SELL rating with 95% confidence, while PTIXW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PUBC vs PTIXW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PUBC vs PTIXW, the AI consensus favors PUBC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.